CDMOs
World’s Most Productive Companies
CDMOs
Contract Development and Manufacturing Organizations produce drugs and biologics under contract for pharmaceutical and biotech clients. Productivity tracks capacity utilization, batch yields, and the shift toward higher-value biologics and specialized modalities. Scale, regulatory track record, and the ability to flex across modalities separate the leaders in a fundamentally capacity-driven business.
The group had a strong 2025, finishing about 1% above its 2019 baseline. No company in the group reached the 2026 World’s Most Productive Companies list this year. Every company in the group improved on the year.
Productivity Snapshot
- CDMOs ranks sixth of eight Life Sciences peer groups in 2025, at an Industrial Productivity Index of 1.01, about 1% above its 2019 baseline.
- 3 of 3 companies grew productivity in 2025.
- No company in the group earned a place on the 2026 World’s Most Productive Companies list this year.
- All three companies improved in 2025, lifting the group back above its 2019 baseline as demand for outsourced capacity recovered.
Interested in learning more about how you stack up, where to improve, and the impact on margin, cash, inventory, and assets?